The deaths have increased significantly since 2007, scientists of the EU center for disease control ECDC, reported in the journal Lancet Infectious Diseases. To date, the experts were assumed to be approximately 25,000 cases per year.
2015 killed about 2400 German by mulitresistente germs. In Italy 10.762 people even fell for such an infection to the victim. Most of the ECDC are at risk, newborns and children in the first year of life.
Dr. Michael Ebenhoch, head of the Department of infectiology at the BG trauma clinic in Murnau, said the issue is now in the BR:
"We have seen over the last few years, increasingly more patients who are colonized with multi-resistant pathogens and also infections, in part due to no longer suffer, only to a very limited extent, or in some cases even treatable with the antibiotics."
The dangerous bacteria occur mostly in hospitals and transferring patients, you in the gut or on the skin, on the other.
Reserve antibiotics used in an inflationary way
The so-called reserve antibiotics are the last hope for patients infected with multi-resistant germs. You should normally only be prescribed when other antibiotics help. Many Doctors treat nevertheless often immediately with broad-spectrum antibiotics.
This is a big Problem, because the more they are used, the faster resistance. About 30 percent of all regulations could be avoided. Also, the high use of antibiotics in agriculture is problematic.
Resistance to take
Since 2018, the resistance to the class of so-called gram-negative Intestinal bacteria, such as it is, when BR. At the same time be reserve antibiotics increasingly ineffective. Dr. Tim Eckmanns Robert Koch Institute is concerned about this development. Because then you would only "Reserve Reserve Antiobiotika" as he said to the BR. The Problem is that This would have many side effects.
OECD raises the Alarm
The Organisation for economic co-operation and development (OECD), the Commission proposed already last autumn alert: In rich countries, it could come because of the super germs by 2050 to 2.4 million deaths.
In the analysis it is stated: “In Europe will not have the doubled Occurrence of germs that are resistant to such reserve antibiotics, in the period from 2005 to 2030, if we fight with renewed efforts.”
Of the 2.4 million deaths that could fall by 2050 in North America, Europe and Australia, the super-germs to the victim, is likely to around 100,000 from Germany. For the USA the forecast is even much worse: every Year, there are 30,000 people could lose their lives.
The risk is actually already known for a long time, but so far has not been taken according to the OECD, enough. Therefore, the organization proposes three counter-measures:
Firstly, antibiotics should be less prescribed generous. Then the germs could make no further resistance.
Secondly, the Hygiene in hospitals needs to be improved.
Finally, countries are investing more money in the development of better medicines. So many deaths were cases prevent.
New antibiotics are not developed
In the manufacture of antibiotics promising ideas from the basic research. For pharmaceutical companies, the distribution of reserve antibiotics is also very lucrative, as Dr. Siegfried Throm Association of research-based pharmaceutical manufacturers, the BR explains:
"If such an antibiotic is then placed in the market, it is used extremely rarely. Therefore, the previous business model of the industry does not work in this case." Because this is based on: "I develop with great effort a new medication, and then earn, as long as the patent protection, the application of this drug in many patients."